Project Grant R01HD121028
- The National Institute of Child Health and Human Development awarded The Children's Hospital Corporation (doing business as Boston Children's Hospital) $431,781 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the impacts of genetic testing in individuals with cerebral palsy. The project will examine family perspectives on the psychosocial impact and utility of genetic testing for cerebral palsy, assess whether a genetic...
- This $330,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to characterize the functional and anatomical connectivity of motor pathways in children with unilateral cerebral palsy (UCP). The primary objectives are to use multimodal neuroimaging techniques, including functional near-infrared spectroscopy and transcranial magnetic stimulation, to identify...
- The National Institute of Child Health and Human Development awarded the University of Washington $383,200 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to optimize transcutaneous spinal cord stimulation intensity for gait training in children with cerebral palsy. The research systematically evaluates how varying spinal stimulation intensities affect gait biomechanics in ambulatory children with bilateral cerebral palsy. In the first aim,...
- The National Institute of Child Health and Human Development awarded the University of Washington $616,250 on September 1, 2026, through the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a randomized controlled trial evaluating non-invasive spinal cord stimulation combined with intensive treadmill training to reduce spasticity and improve mobility in children with cerebral palsy. The research will enroll children with cerebral palsy in a 24-session...
- Federal Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $472,325 Project Grant to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab) on August 4, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The project, "Quantifying Selective Motor Control in Preterm Infants: A Computer Vision Approach," will develop and validate a computer...
- The National Institute of Child Health and Human Development awarded The Trustees of The University of Pennsylvania $444,470 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.HDR) to develop a learning-from-demonstration framework enabling rehabilitation robots to automatically learn optimal assistance patterns from expert therapist demonstrations while adapting to individual patient capabilities in stroke neurorehabilitation. The research...
- The National Institute of Child Health and Human Development awarded the University of California, Davis $127,557 on September 30, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to evaluate force-based and position-based prosthetic control systems for children born without a hand. The research fuses surface electromyography (sEMG), which measures electrical muscle activity, with sonomyography (ultrasound), which images muscle deformation within the...
- The National Institute of Child Health and Human Development awarded The Children's Hospital of Philadelphia $356,000 on May 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to analyze disease trajectories of rare genomic variants contributing to childhood lesional brain disorders and epilepsies. The recipient will integrate genomic sequencing data from two Kids First cohorts—one focused on epilepsy and one on brain tumors—with longitudinal...
- The National Institute of Child Health and Human Development awarded $765,377 to The Children's Hospital of Philadelphia on June 17, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to establish clinical trial readiness of magnetoencephalography (MEG) biomarkers in children across the autism spectrum. The award funds a 12-week repeated scanning design study to standardize and validate two leading MEG measures—diminished and delayed auditory evoked...
- The National Institute of Neurological Disorders and Stroke awarded The Children's Hospital of Philadelphia $219,658 on May 19, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to validate wearable magnetoencephalography (MEG) technology for presurgical language mapping in pediatric epilepsy patients. The project develops and tests a wearable MEG array based on optically pumped magnetometer (OPM) technology that does not require...
The National Institute of Child Health and Human Development awarded The Children's Hospital of Philadelphia $482,901 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop precise measurement approaches for selective motor control impairment in children with cerebral palsy. The research characterizes patterns of impaired motor control in cerebral palsy using electromyography paired with biofeedback during single-joint movement tasks. The methodology quantifies four index values of selective motor control—coactivation, mirroring, synergy, and total overflow—for six lower limb joint actions (hip extension, hip abduction, knee extension, knee flexion, ankle dorsiflexion, and ankle plantarflexion). A biofeedback game maintains engagement while performing the measurement protocol. The long-term objective is to develop personalized measures that predict treatment response and guide individualized treatment decisions, addressing the current gap in clinical practice where variability in treatment response to cerebral palsy interventions remains high due to failure to match treatments to individual patterns of motor control impairment. The award is structured as a Project Grant with a period of performance through June 30, 2031. Performance takes place in Philadelphia, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $482.9k | 8/31/26 |